Global Patient Derived Xenograft Models Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Patient Derived Xenograft Models Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Patient Derived Xenograft Models Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Mice Models
  • 1.2.3 Rat Models
• 1.3 Market by Application
  • 1.3.1 Global Patient Derived Xenograft Models Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Pharmaceutical & Biotechnology Companies
  • 1.3.3 Contract Research Organizations
  • 1.3.4 Academic & Research Institutions
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Patient Derived Xenograft Models Sales Estimates and Forecasts 2017-2028
• 2.2 Global Patient Derived Xenograft Models Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Patient Derived Xenograft Models Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Patient Derived Xenograft Models Sales by Region
  • 2.4.1 Global Patient Derived Xenograft Models Sales by Region (2017-2022)
  • 2.4.2 Global Sales Patient Derived Xenograft Models by Region (2023-2028)
• 2.5 Global Patient Derived Xenograft Models Revenue by Region
  • 2.5.1 Global Patient Derived Xenograft Models Revenue by Region (2017-2022)
  • 2.5.2 Global Patient Derived Xenograft Models Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Patient Derived Xenograft Models Sales by Manufacturers
  • 3.1.1 Global Top Patient Derived Xenograft Models Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Patient Derived Xenograft Models Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Patient Derived Xenograft Models in 2021
• 3.2 Global Patient Derived Xenograft Models Revenue by Manufacturers
  • 3.2.1 Global Patient Derived Xenograft Models Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Patient Derived Xenograft Models Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Patient Derived Xenograft Models Revenue in 2021
• 3.3 Global Patient Derived Xenograft Models Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Patient Derived Xenograft Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Patient Derived Xenograft Models Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Patient Derived Xenograft Models Sales by Type
  • 4.1.1 Global Patient Derived Xenograft Models Historical Sales by Type (2017-2022)
  • 4.1.2 Global Patient Derived Xenograft Models Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• 4.2 Global Patient Derived Xenograft Models Revenue by Type
  • 4.2.1 Global Patient Derived Xenograft Models Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Patient Derived Xenograft Models Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• 4.3 Global Patient Derived Xenograft Models Price by Type
  • 4.3.1 Global Patient Derived Xenograft Models Price by Type (2017-2022)
  • 4.3.2 Global Patient Derived Xenograft Models Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Patient Derived Xenograft Models Sales by Application
  • 5.1.1 Global Patient Derived Xenograft Models Historical Sales by Application (2017-2022)
  • 5.1.2 Global Patient Derived Xenograft Models Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• 5.2 Global Patient Derived Xenograft Models Revenue by Application
  • 5.2.1 Global Patient Derived Xenograft Models Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Patient Derived Xenograft Models Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• 5.3 Global Patient Derived Xenograft Models Price by Application
  • 5.3.1 Global Patient Derived Xenograft Models Price by Application (2017-2022)
  • 5.3.2 Global Patient Derived Xenograft Models Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Patient Derived Xenograft Models Market Size by Type
  • 6.1.1 North America Patient Derived Xenograft Models Sales by Type (2017-2028)
  • 6.1.2 North America Patient Derived Xenograft Models Revenue by Type (2017-2028)
• 6.2 North America Patient Derived Xenograft Models Market Size by Application
  • 6.2.1 North America Patient Derived Xenograft Models Sales by Application (2017-2028)
  • 6.2.2 North America Patient Derived Xenograft Models Revenue by Application (2017-2028)
• 6.3 North America Patient Derived Xenograft Models Market Size by Country
  • 6.3.1 North America Patient Derived Xenograft Models Sales by Country (2017-2028)
  • 6.3.2 North America Patient Derived Xenograft Models Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Patient Derived Xenograft Models Market Size by Type
  • 7.1.1 Europe Patient Derived Xenograft Models Sales by Type (2017-2028)
  • 7.1.2 Europe Patient Derived Xenograft Models Revenue by Type (2017-2028)
• 7.2 Europe Patient Derived Xenograft Models Market Size by Application
  • 7.2.1 Europe Patient Derived Xenograft Models Sales by Application (2017-2028)
  • 7.2.2 Europe Patient Derived Xenograft Models Revenue by Application (2017-2028)
• 7.3 Europe Patient Derived Xenograft Models Market Size by Country
  • 7.3.1 Europe Patient Derived Xenograft Models Sales by Country (2017-2028)
  • 7.3.2 Europe Patient Derived Xenograft Models Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Patient Derived Xenograft Models Market Size by Type
  • 8.1.1 Asia Pacific Patient Derived Xenograft Models Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Patient Derived Xenograft Models Revenue by Type (2017-2028)
• 8.2 Asia Pacific Patient Derived Xenograft Models Market Size by Application
  • 8.2.1 Asia Pacific Patient Derived Xenograft Models Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Patient Derived Xenograft Models Revenue by Application (2017-2028)
• 8.3 Asia Pacific Patient Derived Xenograft Models Market Size by Region
  • 8.3.1 Asia Pacific Patient Derived Xenograft Models Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Patient Derived Xenograft Models Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Patient Derived Xenograft Models Market Size by Type
  • 9.1.1 Latin America Patient Derived Xenograft Models Sales by Type (2017-2028)
  • 9.1.2 Latin America Patient Derived Xenograft Models Revenue by Type (2017-2028)
• 9.2 Latin America Patient Derived Xenograft Models Market Size by Application
  • 9.2.1 Latin America Patient Derived Xenograft Models Sales by Application (2017-2028)
  • 9.2.2 Latin America Patient Derived Xenograft Models Revenue by Application (2017-2028)
• 9.3 Latin America Patient Derived Xenograft Models Market Size by Country
  • 9.3.1 Latin America Patient Derived Xenograft Models Sales by Country (2017-2028)
  • 9.3.2 Latin America Patient Derived Xenograft Models Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Patient Derived Xenograft Models Market Size by Type
  • 10.1.1 Middle East and Africa Patient Derived Xenograft Models Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Patient Derived Xenograft Models Market Size by Application
  • 10.2.1 Middle East and Africa Patient Derived Xenograft Models Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Patient Derived Xenograft Models Market Size by Country
  • 10.3.1 Middle East and Africa Patient Derived Xenograft Models Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Crown Bioscience Inc. (US)
  • 11.1.1 Crown Bioscience Inc. (US) Corporation Information
  • 11.1.2 Crown Bioscience Inc. (US) Overview
  • 11.1.3 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Crown Bioscience Inc. (US) Recent Developments
• 11.2 WuXi AppTec (China)
  • 11.2.1 WuXi AppTec (China) Corporation Information
  • 11.2.2 WuXi AppTec (China) Overview
  • 11.2.3 WuXi AppTec (China) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 WuXi AppTec (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 WuXi AppTec (China) Recent Developments
• 11.3 Champions Oncology (US)
  • 11.3.1 Champions Oncology (US) Corporation Information
  • 11.3.2 Champions Oncology (US) Overview
  • 11.3.3 Champions Oncology (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Champions Oncology (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Champions Oncology (US) Recent Developments
• 11.4 The Jackson Laboratory (US)
  • 11.4.1 The Jackson Laboratory (US) Corporation Information
  • 11.4.2 The Jackson Laboratory (US) Overview
  • 11.4.3 The Jackson Laboratory (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 The Jackson Laboratory (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 The Jackson Laboratory (US) Recent Developments
• 11.5 ONCODESIGN (France)
  • 11.5.1 ONCODESIGN (France) Corporation Information
  • 11.5.2 ONCODESIGN (France) Overview
  • 11.5.3 ONCODESIGN (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 ONCODESIGN (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 ONCODESIGN (France) Recent Developments
• 11.6 Charles River Laboratories International (US)
  • 11.6.1 Charles River Laboratories International (US) Corporation Information
  • 11.6.2 Charles River Laboratories International (US) Overview
  • 11.6.3 Charles River Laboratories International (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Charles River Laboratories International (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Charles River Laboratories International (US) Recent Developments
• 11.7 EPO Berlin-Buch GmBH (Germany)
  • 11.7.1 EPO Berlin-Buch GmBH (Germany) Corporation Information
  • 11.7.2 EPO Berlin-Buch GmBH (Germany) Overview
  • 11.7.3 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 EPO Berlin-Buch GmBH (Germany) Recent Developments
• 11.8 Shanghai LIDE Biotech Co., Ltd (China)
  • 11.8.1 Shanghai LIDE Biotech Co., Ltd (China) Corporation Information
  • 11.8.2 Shanghai LIDE Biotech Co., Ltd (China) Overview
  • 11.8.3 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Shanghai LIDE Biotech Co., Ltd (China) Recent Developments
• 11.9 Xentech (France)
  • 11.9.1 Xentech (France) Corporation Information
  • 11.9.2 Xentech (France) Overview
  • 11.9.3 Xentech (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Xentech (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Xentech (France) Recent Developments
• 11.10 Horizon Discovery Group PLC (UK)
  • 11.10.1 Horizon Discovery Group PLC (UK) Corporation Information
  • 11.10.2 Horizon Discovery Group PLC (UK) Overview
  • 11.10.3 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Horizon Discovery Group PLC (UK) Recent Developments
• 11.11 Urolead (France)
  • 11.11.1 Urolead (France) Corporation Information
  • 11.11.2 Urolead (France) Overview
  • 11.11.3 Urolead (France) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Urolead (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Urolead (France) Recent Developments
• 11.12 Explora BioLabs (US)
  • 11.12.1 Explora BioLabs (US) Corporation Information
  • 11.12.2 Explora BioLabs (US) Overview
  • 11.12.3 Explora BioLabs (US) Patient Derived Xenograft Models Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Explora BioLabs (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Explora BioLabs (US) Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Patient Derived Xenograft Models Industry Chain Analysis
• 12.2 Patient Derived Xenograft Models Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Patient Derived Xenograft Models Production Mode & Process
• 12.4 Patient Derived Xenograft Models Sales and Marketing
  • 12.4.1 Patient Derived Xenograft Models Sales Channels
  • 12.4.2 Patient Derived Xenograft Models Distributors
• 12.5 Patient Derived Xenograft Models Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Patient Derived Xenograft Models Industry Trends
• 13.2 Patient Derived Xenograft Models Market Drivers
• 13.3 Patient Derived Xenograft Models Market Challenges
• 13.4 Patient Derived Xenograft Models Market Restraints

14 Key Findings in The Global Patient Derived Xenograft Models Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

LIST OF TABLES

List of Tables

• Table 1. Global Patient Derived Xenograft Models Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Mice Models
• Table 3. Major Manufacturers of Rat Models
• Table 4. Global Patient Derived Xenograft Models Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Patient Derived Xenograft Models Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
• Table 7. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
• Table 8. Global Patient Derived Xenograft Models Sales by Region (2023-2028) & (K Units)
• Table 9. Global Patient Derived Xenograft Models Sales Market Share by Region (2023-2028)
• Table 10. Global Patient Derived Xenograft Models Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Patient Derived Xenograft Models Revenue Market Share by Region (2017-2022)
• Table 12. Global Patient Derived Xenograft Models Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Patient Derived Xenograft Models Revenue Market Share by Region (2023-2028)
• Table 14. Global Patient Derived Xenograft Models Sales by Manufacturers (2017-2022) & (K Units)
• Table 15. Global Patient Derived Xenograft Models Sales Share by Manufacturers (2017-2022)
• Table 16. Global Patient Derived Xenograft Models Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Patient Derived Xenograft Models Revenue Share by Manufacturers (2017-2022)
• Table 18. Patient Derived Xenograft Models Price by Manufacturers (2017-2022) &(USD/Unit)
• Table 19. Global Patient Derived Xenograft Models Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Patient Derived Xenograft Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patient Derived Xenograft Models as of 2021)
• Table 21. Patient Derived Xenograft Models Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Patient Derived Xenograft Models Product Offered
• Table 23. Date of Manufacturers Enter into Patient Derived Xenograft Models Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 26. Global Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 27. Global Patient Derived Xenograft Models Sales Share by Type (2017-2022)
• Table 28. Global Patient Derived Xenograft Models Sales Share by Type (2023-2028)
• Table 29. Global Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Patient Derived Xenograft Models Revenue Share by Type (2017-2022)
• Table 32. Global Patient Derived Xenograft Models Revenue Share by Type (2023-2028)
• Table 33. Patient Derived Xenograft Models Price by Type (2017-2022) & (USD/Unit)
• Table 34. Global Patient Derived Xenograft Models Price Forecast by Type (2023-2028) & (USD/Unit)
• Table 35. Global Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 36. Global Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 37. Global Patient Derived Xenograft Models Sales Share by Application (2017-2022)
• Table 38. Global Patient Derived Xenograft Models Sales Share by Application (2023-2028)
• Table 39. Global Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Patient Derived Xenograft Models Revenue Share by Application (2017-2022)
• Table 42. Global Patient Derived Xenograft Models Revenue Share by Application (2023-2028)
• Table 43. Patient Derived Xenograft Models Price by Application (2017-2022) & (USD/Unit)
• Table 44. Global Patient Derived Xenograft Models Price Forecast by Application (2023-2028) & (USD/Unit)
• Table 45. North America Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 46. North America Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 47. North America Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 50. North America Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 51. North America Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
• Table 54. North America Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
• Table 55. North America Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 58. Europe Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 59. Europe Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 62. Europe Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 63. Europe Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
• Table 66. Europe Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
• Table 67. Europe Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 70. Asia Pacific Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 71. Asia Pacific Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 74. Asia Pacific Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 75. Asia Pacific Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Patient Derived Xenograft Models Sales by Region (2017-2022) & (K Units)
• Table 78. Asia Pacific Patient Derived Xenograft Models Sales by Region (2023-2028) & (K Units)
• Table 79. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Patient Derived Xenograft Models Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 82. Latin America Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 83. Latin America Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 86. Latin America Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 87. Latin America Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
• Table 90. Latin America Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
• Table 91. Latin America Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Patient Derived Xenograft Models Sales by Type (2017-2022) & (K Units)
• Table 94. Middle East and Africa Patient Derived Xenograft Models Sales by Type (2023-2028) & (K Units)
• Table 95. Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Patient Derived Xenograft Models Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Patient Derived Xenograft Models Sales by Application (2017-2022) & (K Units)
• Table 98. Middle East and Africa Patient Derived Xenograft Models Sales by Application (2023-2028) & (K Units)
• Table 99. Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Patient Derived Xenograft Models Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2017-2022) & (K Units)
• Table 102. Middle East and Africa Patient Derived Xenograft Models Sales by Country (2023-2028) & (K Units)
• Table 103. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Patient Derived Xenograft Models Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Crown Bioscience Inc. (US) Corporation Information
• Table 106. Crown Bioscience Inc. (US) Description and Major Businesses
• Table 107. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 108. Crown Bioscience Inc. (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Crown Bioscience Inc. (US) Recent Developments
• Table 110. WuXi AppTec (China) Corporation Information
• Table 111. WuXi AppTec (China) Description and Major Businesses
• Table 112. WuXi AppTec (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 113. WuXi AppTec (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. WuXi AppTec (China) Recent Developments
• Table 115. Champions Oncology (US) Corporation Information
• Table 116. Champions Oncology (US) Description and Major Businesses
• Table 117. Champions Oncology (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 118. Champions Oncology (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Champions Oncology (US) Recent Developments
• Table 120. The Jackson Laboratory (US) Corporation Information
• Table 121. The Jackson Laboratory (US) Description and Major Businesses
• Table 122. The Jackson Laboratory (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 123. The Jackson Laboratory (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. The Jackson Laboratory (US) Recent Developments
• Table 125. ONCODESIGN (France) Corporation Information
• Table 126. ONCODESIGN (France) Description and Major Businesses
• Table 127. ONCODESIGN (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 128. ONCODESIGN (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. ONCODESIGN (France) Recent Developments
• Table 130. Charles River Laboratories International (US) Corporation Information
• Table 131. Charles River Laboratories International (US) Description and Major Businesses
• Table 132. Charles River Laboratories International (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 133. Charles River Laboratories International (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Charles River Laboratories International (US) Recent Developments
• Table 135. EPO Berlin-Buch GmBH (Germany) Corporation Information
• Table 136. EPO Berlin-Buch GmBH (Germany) Description and Major Businesses
• Table 137. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 138. EPO Berlin-Buch GmBH (Germany) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. EPO Berlin-Buch GmBH (Germany) Recent Developments
• Table 140. Shanghai LIDE Biotech Co., Ltd (China) Corporation Information
• Table 141. Shanghai LIDE Biotech Co., Ltd (China) Description and Major Businesses
• Table 142. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 143. Shanghai LIDE Biotech Co., Ltd (China) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Shanghai LIDE Biotech Co., Ltd (China) Recent Developments
• Table 145. Xentech (France) Corporation Information
• Table 146. Xentech (France) Description and Major Businesses
• Table 147. Xentech (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 148. Xentech (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Xentech (France) Recent Developments
• Table 150. Horizon Discovery Group PLC (UK) Corporation Information
• Table 151. Horizon Discovery Group PLC (UK) Description and Major Businesses
• Table 152. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 153. Horizon Discovery Group PLC (UK) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Horizon Discovery Group PLC (UK) Recent Developments
• Table 155. Urolead (France) Corporation Information
• Table 156. Urolead (France) Description and Major Businesses
• Table 157. Urolead (France) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 158. Urolead (France) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Urolead (France) Recent Developments
• Table 160. Explora BioLabs (US) Corporation Information
• Table 161. Explora BioLabs (US) Description and Major Businesses
• Table 162. Explora BioLabs (US) Patient Derived Xenograft Models Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 163. Explora BioLabs (US) Patient Derived Xenograft Models Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Explora BioLabs (US) Recent Developments
• Table 165. Key Raw Materials Lists
• Table 166. Raw Materials Key Suppliers Lists
• Table 167. Patient Derived Xenograft Models Distributors List
• Table 168. Patient Derived Xenograft Models Customers List
• Table 169. Patient Derived Xenograft Models Market Trends
• Table 170. Patient Derived Xenograft Models Market Drivers
• Table 171. Patient Derived Xenograft Models Market Challenges
• Table 172. Patient Derived Xenograft Models Market Restraints
• Table 173. Research Programs/Design for This Report
• Table 174. Key Data Information from Secondary Sources
• Table 175. Key Data Information from Primary Sources

List of Figures

• Figure 1. Patient Derived Xenograft Models Product Picture
• Figure 3. Global Patient Derived Xenograft Models Market Share by Type in 2021 & 2028
• Figure 3. Mice Models Product Picture
• Figure 4. Rat Models Product Picture
• Figure 5. Global Patient Derived Xenograft Models Market Share by Application in 2021 & 2028
• Figure 6. Pharmaceutical & Biotechnology Companies
• Figure 7. Contract Research Organizations
• Figure 8. Academic & Research Institutions
• Figure 9. Patient Derived Xenograft Models Report Years Considered
• Figure 10. Global Patient Derived Xenograft Models Sales 2017-2028 (K Units)
• Figure 11. Global Patient Derived Xenograft Models Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Patient Derived Xenograft Models Revenue 2017-2028 (US$ Million)
• Figure 13. Global Patient Derived Xenograft Models Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Patient Derived Xenograft Models Sales Market Share by Region (2017-2022)
• Figure 15. Global Patient Derived Xenograft Models Sales Market Share by Region (2023-2028)
• Figure 16. North America Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
• Figure 17. North America Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
• Figure 19. Europe Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
• Figure 21. Asia-Pacific Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
• Figure 23. Latin America Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Patient Derived Xenograft Models Sales YoY (2017-2028) & (K Units)
• Figure 25. Middle East & Africa Patient Derived Xenograft Models Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Patient Derived Xenograft Models Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Patient Derived Xenograft Models in the World: Market Share by Patient Derived Xenograft Models Revenue in 2021
• Figure 28. Global Patient Derived Xenograft Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 30. Global Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 31. Global Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 32. Global Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 33. North America Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 34. North America Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 35. North America Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 36. North America Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 37. North America Patient Derived Xenograft Models Sales Share by Country (2017-2028)
• Figure 38. North America Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
• Figure 39. U.S. Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 42. Europe Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 44. Europe Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Patient Derived Xenograft Models Sales Share by Country (2017-2028)
• Figure 46. Europe Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
• Figure 47. Germany Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 48. France Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Patient Derived Xenograft Models Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Patient Derived Xenograft Models Revenue Share by Region (2017-2028)
• Figure 58. China Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 61. India Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 63. Taiwan Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 67. Philippines Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 69. Latin America Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 70. Latin America Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Patient Derived Xenograft Models Sales Share by Country (2017-2028)
• Figure 73. Latin America Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
• Figure 74. Mexico Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Patient Derived Xenograft Models Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Patient Derived Xenograft Models Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Patient Derived Xenograft Models Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Patient Derived Xenograft Models Revenue Share by Country (2017-2028)
• Figure 83. Turkey Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 85. U.A.E Patient Derived Xenograft Models Revenue (2017-2028) & (US$ Million)
• Figure 86. Patient Derived Xenograft Models Value Chain
• Figure 87. Patient Derived Xenograft Models Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed